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Streptomyces coelicolor strains lacking polyprenol phosphate
mannose synthase and protein O-mannosyl transferase are
hyper-susceptible to multiple antibiotics
Robert Howlett,1† Nicholas Read,1† Anpu Varghese,2 Charles Kershaw,3 Y. Hancock3,4 and Margaret C. M. Smith1,2,*
Abstract
Polyprenol phosphate mannose (PPM) is a lipid-linked sugar donor used by extra-cytoplasmic glycosyl tranferases in bacteria.
PPM is synthesiszed by polyprenol phosphate mannose synthase, Ppm1, and in most Actinobacteria is used as the sugar donor
for protein O-mannosyl transferase, Pmt, in protein glycosylation. Ppm1 and Pmt have homologues in yeasts and humans,
where they are required for protein O-mannosylation. Actinobacteria also use PPM for lipoglycan biosynthesis. Here we show
that ppm1 mutants of Streptomyces coelicolor have increased susceptibility to a number of antibiotics that target cell wall
biosynthesis. The pmtmutants also have mildly increased antibiotic susceptibilities, in particular to b-lactams and vancomycin.
Despite normal induction of the vancomycin gene cluster, vanSRJKHAX, the pmt and ppm1 mutants remained highly
vancomycin sensitive indicating that the mechanism of resistance is blocked post-transcriptionally. Differential RNA expression
analysis indicated that catabolic pathways were downregulated and anabolic ones upregulated in the ppm1 mutant compared
to the parent or complemented strains. Of note was the increase in expression of fatty acid biosynthetic genes in the ppm1-
mutant. A change in lipid composition was confirmed using Raman spectroscopy, which showed that the ppm1- mutant had a
greater relative proportion of unsaturated fatty acids compared to the parent or the complemented mutant. Taken together,
these data suggest that an inability to synthesize PPM (ppm1) and loss of the glycoproteome (pmt- mutant) can detrimentally
affect membrane or cell envelope functions leading to loss of intrinsic and, in the case of vancomycin, acquired antibiotic
resistance.
INTRODUCTION
In the Actinobacteria, mannose is an important component
of extracellular glycoconjugates including lipoglycans and
glycoproteins [1, 2]. Lipomannan (LM) and lipoarabino-
mannan (LAM) are essential constituents of the cell enve-
lope in mycobacteria [3], and mutants of corynebacteria
that lack these molecules grow poorly [4]. Membrane and
secreted proteins are also modified by mannose residues in
the Actinobacteria and species of Mycobacterium, Coryne-
bacterium and Streptomyces have been shown to contain
glycoproteins [5–9]. Extra-cytoplasmic glycosyl transferases
require a lipid-linked sugar donor, which for the transfer of
mannose is polyprenol phosphate mannose (PPM). The
enzyme polyprenol phosphate mannose synthase, Ppm1,
synthesizes PPM by catalysing the transfer of mannose from
GDP-mannose to polyprenol phosphate on the cytoplasmic
face of the plasma membrane and PPM is then flipped in
the membrane, transporting the mannose moiety to the
periplasm [10] (Fig. 1). In mycobacteria, Ppm1 is an essen-
tial enzyme as it is required for lipomannan biosynthesis
[11], and Corynebacterium ppm1 mutants have a reduced
growth rate [12].
We are interested in the role of protein O-glycosylation in
bacteria and ultimately we aim to understand how the gly-
cans affect protein function. The protein O-glycosylation
pathway in the Actinobacteria is highly reminiscent of the
O-mannosylation pathway in yeasts and humans [2, 9, 13].
In fungi, mutations that inactivate PMTs lead to loss of fit-
ness and/or avirulent phenotypes [14–19]. In humans, loss
of PoMT leads to a developmental phenotype [20]. Overall
the evidence suggests that protein O-mannosylation is a
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fundamentally important protein modification in prokar-
yotes and eukaryotes.
S. coelicolor is a convenient model to study the protein O-gly-
cosylation pathway in bacteria, as the pmt and ppm1 genes
are not essential [21, 22] and Streptomyces spp. are not known
to generate the heavily glycosylated lipomannans and lipoara-
binomannans that require Ppm1 for synthesis. In previous
work we showed that S. coelicolor Ppm1 (SCO1423) catalyses
the transfer of mannose from GDP-mannose to polyprenol
phosphate to generate PPM, and Pmt (SCO3154) was shown
to transfer mannose from PPM to target peptides [9] (Fig. 1).
Ppm1 and Pmt activities are confined to the membrane frac-
tions. The periplasmic phosphate-binding protein, PstS, part
of a high-affinity phosphate uptake system, was shown to be
O-glycosylated with a trihexose [9]. The enzymes Pmt and
Ppm1 were first identified as being required for phage fC31
infection, suggesting that the phage receptor is a glycoprotein
(s) [21, 22].
Here we report on the global phenotypes of mutations that
lead to an inability to synthesize PPM and the glycopro-
teome in S. coelicolor. Mutations in pmt and ppm1 confer
pleiotropic phenotypes including increased susceptibilities to
multiple antibiotics, most of which act at different stages of
cell wall biogenesis. Global transcriptional analysis in the
ppm1– mutant compared to the parent (ppm1+) strain
showed that this mutation conferred a general switch from
catabolism to anabolism and a major change in fatty acid
metabolism. Changes in lipid composition in the ppm1-
mutant were confirmed using Raman spectroscopy. We
propose that these global effects on the cell envelope affect
periplasmic and membrane protein function, leading to anti-
biotic susceptibility.
METHODS
Bacterial strains
Streptomyces coelicolor strains with mutations in ppm1
(DT3017; ppm1E218V, DT1020; ppm1H116D and DT1029;
ppm1S163L) and pmt (DT1025; frameshift from A121, and
DT2008; mutation uncharacterized) were obtained previ-
ously [21, 22]. E. coli strain DH5a was used for propagation
of plasmids pDT10 and pDT16, also published previously
[21, 22]. The DNA methylation-deficient strain of E. coli,
ET12567 (pUZ8002), was used as the donor host for plas-
mid conjugation to Streptomyces species as described previ-
ously [23, 24]. Streptomyces strains were routinely
maintained on soya mannitol (SM) agar at 30

C [24] and
spore stocks maintained at  38

C.
Disc diffusion assays
Difco nutrient (DN) agar plates were evenly spread with
approximately 1107 Streptomyces spores. Sterile filter discs
(5mm width) were placed on the surface of the inoculated
agar plates and 10 µl of an antibiotic stock solution was
allowed to absorb to the disc. Plates were incubated at 30

C
for 2 days and the zones of inhibition were measured. At
least three biological replicates and at least two technical
replicates were used for each strain.
Quantitative mRNA analysis and culture conditions
Samples were prepared for quantitative reverse transcrip-
tase-polymerase chain reaction (qRT-PCR) analysis by
inoculation of 500ml DN broth in a 2 l baffled flask to a
starting OD450 of 0.05 with heat-shocked pre-germinated
spores. Pre-germination was performed according to Kieser
et al. [24]; approximately 109 c.f.u. S. coelicolor spores were
germinated for 10 h in 100ml germination medium in 1 l
Fig. 1. The protein O-glycosylation pathway in S. coelicolor. Two enzyme activities, Ppm1 and Pmt (encoded by sco1423 and sco3154,
respectively), required for glycosylation of the periplasmic phosphate-binding protein, PstS, are membrane bound [9]. In vitro Ppm1
transfers mannose from GDP-mannose to a nonaprenol to generate polyprenol phosphate mannose, which then acts as the sugar car-
rier for Pmt to glycosylate peptides containing a glycosylation site [9]. In Mycobacterium tuberculosis protein, O-glycosylation was asso-
ciated with the secretion apparatus [13].
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baffled flasks at 30

C. Cultures were then grown at 30

C for
6 h at 250 r.p.m. before the addition of vancomycin to a final
concentration of 0.1 µgml 1. Next, 43ml of culture was
sampled and added to 7ml stop solution (5% phenol in eth-
anol, stored at –20

C) at time-points 0, 30, 60 and 90min.
RNA was extracted from samples as described below and
cDNA was created using SuperScript III reverse transcrip-
tase (Life technologies) using the manufacturer’s instruc-
tions with the following altered temperature cycle: 25

C,
10min; 42

C, 120min; 50

C, 30min; 55

C, 30min; 85

C,
5min. Primers used for qRT-PCR were designed using
Primer3 software [25]. Reactions were carried out on a Ste-
pOne PCR machine (Applied Biosystems) with each 20 µl
qRT-PCR reaction containing 10 µl Fast SYBR Green Mast
Mix (Applied Biosystems) 25 ng cDNA and optimized
primer and DMSO concentrations. Optimized conditions
were as follows: primers RH111 and RH112 300 nM no
DMSO; RH107 and RH108 500 nM with 4.8% DMSO;
RH109 and RH110 200 nM with 4.8% DMSO (Table S1,
available in the online version of this article). The principal
sigma factor of S. coelicolor (hrdB) was used as a representa-
tive constitutively expressed, housekeeping gene.
Fermentor cultivation conditions
Cultivations for RNAseq analysis were performed in 7 l fer-
mentors (Applikon) containing 2.5 l of DN broth and 2ml
antifoam C emulsion (Sigma-Aldrich), with a starting pH
adjusted to 7 with NaOH. Temperature was maintained at
30

C and pH maintained at 7 through the automatic addi-
tion of 2 M HCl. Dissolved oxygen was maintained at a
minimum of 30% by automatic adjustment of the agitation
speed, with a minimum and maximum rate of 300 and 1000
,respectively, and a constant aeration pressure of 2.5–
3.5 bar. For the inoculum approximately 109 c.f.u. S. coeli-
color spores were germinated for 10 h in 100ml germination
medium in 1 l baffled flasks at 30

C following heat shock as
described in Kieser et al. [24], before being used to inoculate
equilibrated fermentor culture medium to an OD450 of 0.05.
Growth was measured using dry weight while dissolved
oxygen, pH, agitation speed and temperature were logged
online throughout.
Isolation of RNA and transcriptome analysis
RNA for RNAseq analysis was isolated from fermentor-
grown cultures as described above. The equivalent of 40
OD600 units were sampled and immediately added to 1/8
volume stop solution (5% phenol in ethanol, stored at
–20

C). Cultures were spun down at 12 000 r.p.m., 4

C for
5min before pellets were flash-frozen in liquid nitrogen
and stored at  80

C for future processing. RNA isolation
was performed using a modified version of the Kirby mix
protocol as follows [24]: 14 g of glass beads were added to
defrosted pellets along with 5ml of 30

C modified Kirby
mix before being vigorously vortexed for 2min. Acid phe-
nol:chloroform 1 : 1 was then used to isolate nucleic acids
before being precipitated with 4 M acetate and 100% iso-
propanol. Nucleic acids were subject to an ethanol wash
before final resuspension in water. Nucleic acids were
repeatedly treated with DNase I using conditions described
by the vendor (Roche) until DNA could no longer be
amplified using polymerase chain reaction (PCR). RNA
was then enriched for mRNA using MICROBExpress Bac-
teria beads, as described by the manufacturer (Ambion).
The use of stop solution to prevent artefacts due to variation
in harvesting of samples was validated as follows: two sam-
ples were collected from the fermentor (containing J1929,
time point 24 h) and stop solution was added to both. RNA
was prepared immediately for one sample whereas the other
was incubated on ice for 1 h prior to preparation of RNA.
The RNA sequences of both samples was analysed for sig-
nificant changes that might have resulted from RNA degra-
dation. Subsequent linear regression analysis gave an R2 of
0.959, indicating that the use of the stop solution was a valid
procedure for sample preparation (Fig. S2).
Generation of cDNA and production of Illumina HiSeq
data were performed by Vertis Biotechnologie AG (Ger-
many). In brief, mRNAs were fragmented with ultrasound
before Antarctic phosphatase treatment and re-phosphory-
lation with polynucleotide kinase. RNA fragments were
then poly(A)-tailed using poly(A) polymerase, and an RNA
adapter was ligated to mRNA 5¢ phosphate. First-strand
cDNA synthesis was performed using an oligo(dT)-adapter
primer and M-MLV reverse transcriptase before PCR
amplification. The cDNA samples were pooled and size
fractionated in the range 250–500 bp and run on an Illu-
mina HiSeq 2000 system with a 100 bp read length.
Sequences were trimmed using Sickle and aligned to the
S. coelicolor genome (NCBI, accession number NC_003888)
using BWA MEM (http://bio-bwa.sourceforge.net). Nor-
malized counts and differential gene expression analysis
were performed with DESeq2 in RIBioconductor [26]. Gene
ontology analysis was performed using GOEAST [27], and
read counts were visualized using the Integrated Genomics
Viewer [28, 29]. RNA sequencing data is available at the
GEO database accession number GSE107982.
Raman spectroscopy sample preparation
S. coelicolor strains J1929, DT3017 (ppm1– mutant) and
DT3017:pDT16 (complemented mutant) were prepared for
Raman spectroscopy by subjecting spores (approximately
109 c.f.u. in 10ml TES 0.5 M, pH8) to heat shock (50

C, 10
mins) and then adding to 10ml double strength germina-
tion medium in a 250ml baffled conical flask [24]. After
incubation (37

C, 180 r.p.m. for 8–9 h) and centrifugation
to pellet cells, the pellet was resuspended in 40ml DN broth
to an OD450 of 0.05 and incubation continued for a further
12–13 h. Ten millilitres was removed for dry weight mea-
surement and the remaining culture was centrifuged, the
cell pellet washed once in 30ml high-purity deionized water
and then plated via pipette-deposit directly onto small CaF2
disks (13mm diameter and 1mm thickness). The bacteria
were then gently spread over the disk surface, with excess
water removed by pipette aspiration and then air-dried in a
fume cupboard in preparation for Raman spectroscopy.
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Raman spectroscopy experiments and analyses
Raman spectroscopy point spectra were collected from ran-
domly selected cell populations of S. coelicolor J1929
(parent), DT3017 (ppm1- mutant) and DT3017:pDT16
(complemented mutant) using an HORIBA XploRA micro-
Raman instrument with 532 nm laser, 100 objective (0.9
NA) and 2400 lines/mm spectral grating. Measurements
were made in confocal mode using a laser spot size of
~1 µm, with 3.5mW laser power and 1 cm 1 spectral
resolution.
Spectra were collected using the HORIBA LabSpec 6 soft-
ware in the 600–1800 cm 1 cell-fingerprint and 2750–
3110 cm 1 high-wavenumber ranges. Each spectrum was
obtained using 90s acquisition time averaged over two spec-
tral repetitions, with 40–55 spectra randomly collected
across each cell line over three experimental repeats. The
total number of spectra was averaged to obtain a single rep-
resentative spectrum for each strain.
The averaged spectra were baseline-corrected from the first
to the last spectral point in the fingerprint and high-wave-
number ranges using the ‘Raman tool set’ package [30].
Peak regions in the acquired spectral ranges were then linear
baseline-corrected and Gaussian peak-fitted using IGOR
Pro 6.35 to obtain the peak properties (peak positions, peak
intensities, etc.). Biomolecular peak assignments were made
by correlating the fitted peak positions to literature referen-
ces [31, 32]. The total unsaturated fatty acid (TUFA)/total
fatty acid (TFA) peak intensity ratio for each cell line was
determined with uncertainties calculated from the propa-
gated standard error of the mean in the measured TUFA
and TFA peak intensity values. The percentage standard
error of the mean for the TUFA/TFA ratio was converged
as a function of the number of spectra in each spectral aver-
age, ensuring that sufficient spectra were collected for accu-
rate representation of each sample population.
RESULTS
Mutations in ppm1 and pmt in S. coelicolor confer
hypersensitivity to cell wall-acting antibiotics
S. coelicolor A3(2) J1929 strains with mutations in ppm1
(DT3017, DT1020, DT1029) and pmt (DT2008, DT1025)
were isolated previously [21, 22] (see also Methods). The
ppm1 and pmt mutants display a small colony phenotype
when growing on Difco nutrient agar or soya mannitol agar
that could be complemented by plasmids pDT16 or pDT10,
encoding the wild-type ppm1 or pmt, respectively (Fig. S1).
Microscopic techniques revealed no obvious morphological
differences in the mutant strains so, to probe the underlying
physiological changes, the ppm1 and pmt mutants were sub-
jected to antibiotic stress. Increased sensitivities to a number
of antibiotics, measured using disc diffusion assays, were
detected in multiple independently isolated ppm1– and pmt–
mutant strains (Fig. 2; Dataset S1).
Whilst both ppm1 and pmt mutants had increased suscepti-
bility to ampicillin, imipenem, meropenem, rifampicin and
vancomycin compared to the parent strain, the ppm1
mutants also had greater sensitivity to daptomycin, tunica-
mycin, bacitracin, nisin and ramoplanin. Complementation
of the ppm1– and pmt– mutations with their corresponding
wild-type alleles alleviated the antibiotic-susceptible pheno-
types (Fig. 2). The ppm1 and pmt mutant strains showed no
change in susceptibility to D-cycloserine, polymyxin, mon-
ensin, tetracycline, kanamycin, thiostrepton, chlorampheni-
col, ciprofloxacin and moenomycin, arguing against a
general increase in permeability underlying the antibiotic
susceptible phenotype. Overall, with the exception of rifam-
picin, which targets RNA polymerase, the antibiotics with
increased efficacy on the ppm1– and pmt– mutants act at dif-
ferent stages of cell wall biosynthesis (Fig. 2).
The vancomycin resistance cluster is induced by
vancomycin in the ppm1 and pmt mutants
S. coelicolor encodes a well-characterized vancomycin resis-
tance mechanism conferring a MIC of approximately 80 µg
ml 1 [33, 34]. This mechanism of resistance is shared with
the pathogenic bacterium Enterococcus faecium and
involves reprogramming of cell wall biosynthesis so that the
vancomycin target of the peptidoglycan pentapeptide, the
terminal D-Ala-D-Ala, is replaced by D-Ala-D-Lac [35–37].
The S. coelicolor resistance cluster consists of seven genes
split into four operons: vanRS, a two-component signal
transduction system, vanHAX, encoding enzymes required
for the production of D-Lac, ligation of D-Ala to D-Lac and
breakdown of D-Ala-D-Ala, respectively; vanK, encoding a
Fem protein, a non-ribosomal peptidyltransferase that adds
the cross-bridge amino acids to the stem pentapeptide end-
ing in D-Ala-D-Lac; and vanJ, required for resistance to the
structurally related antibiotic teicoplanin [33, 34, 38].
The addition of vancomycin, but not teicoplanin, induces
expression of the van cluster genes. To test whether the van
cluster was being induced in the ppm1 and pmt mutants, we
measured the level of vanH mRNA (Fig. 3; Dataset S2). As
the ppm1 and pmt mutant strains are highly sensitive to
vancomycin, we used a very low concentration of the drug
to induce (0.1 µgml 1 vancomycin). Even at this low con-
centration the van cluster in the parent strain and in
DT2008 is induced between 10- and 100 -old. The ppm1
mutant strain also showed induction of vanH, but the extent
varied widely from experiment to experiment leading to a
large standard error. This observation and the low levels of
induction in the complemented pmt– strain are most likely
due to the use of a vancomycin concentration for induction
that is at the lower limit. We conclude that failure to tran-
scribe the van cluster in the ppm1 or the pmt mutants is not
the reason why these strains are highly sensitive to vanco-
mycin, and that delivery of resistance in these strains is
blocked post-transcriptionally.
Loss of Ppm1 activity leads to a global switch from
catabolism to anabolism, including a change in
fatty acid metabolism
In order to further our understanding of the underlying pro-
cesses that led to a loss of intrinsic antibiotic resistance, global
Howlett et al., Microbiology
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transcriptional profiling using RNAseq was performed in the
ppm1 mutant, DT3017, the original isogenic parent, J1929,
and the complemented strain, DT3017:pDT16. A ppm1–
mutant was chosen for RNAseq analysis because of the more
extreme phenotype of the ppm1– mutants. Samples were col-
lected during growth under controlled fermentation condi-
tions where DT3017 showed only a modest growth defect
(Fig. S2). Deseq analysis revealed that expression of 658 genes
had changed with a P<0.05 level of significance between
DT3017 and J1929 (461 with a >2-fold difference); 574 of
these changes showed at least some restoration towards J1929
levels in DT3017:pDT16 and were used for further gene
ontology analysis (Dataset S3). The majority (69%) of the
574 genes used for gene ontology analysis were down-regu-
lated in the ppm1mutant compared to the parent, J1929.
Gene ontology analysis showed that membrane and peri-
plasmic functions had been severely affected in the ppm1
mutant. The most prevalent down-regulated genes are asso-
ciated with the GO terms transport and catabolic processes
and in particular organic acid, carbohydrate and amino acid
transport, and carboxylic acid, fatty acid and lipid catabo-
lism are significantly down-regulated (Dataset S4; Table 1).
The GO terms that describe the up-regulated genes are
broadly biosynthetic processes; these notably involve car-
boxylic acids (31 genes), which include fatty acid (9 genes)
and amino acid biosynthesis (19 genes). Sixty-six genes
reached the Benjamini–Hochberg level of significance and
were at least partially restored through complementation
(Table S2). Almost half of the genes in the Benjamini–
Hochberg set for which a function is predicted have a puta-
tive role in lipid metabolism.
Fig. 2. Streptomyces coelicolor strains defective in protein glycosylation genes are hypersensitive to multiple antibiotics. Shown are
diameters of growth inhibition zones from disc diffusion assays for the ppm1– mutants, DT1020, DT1029 and DT3017 against the par-
ent strain J1929 and the complemented strains DT2010:pDT16, DT1029:pDT16 and DT3017:pDT16 (a), and the pmt– mutants, DT1025
and DT2008, the parent strain J1929 and the complemented strains DT1025:pDT10 and DT2008:pDT10 (b). Shown are the averages of
4 replicates with SEM. *Indicates a P<0.05 that the observed difference between the mutant strains versus J1929 has occurred by
chance. The concentration of antibiotic used is shown in parentheses; the full set of antibiotic concentrations used is in Dataset S1. (c)
Diagrammatic summary of antibiotic targets in cell wall biosynthesis.
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Closer inspection of fatty acid metabolism revealed an up-
regulation of all the components of the S. coelicolor ACCase
and FAS II complex (Fig. 4) and a general down-regulation
of a variety of genes predicted to perform b-oxidation and
fatty acid degradation. These results suggest up-regulation
of fatty acid production in DT3017, and hence possible
alterations to membrane composition. Alterations to mem-
brane fluidity, topology and composition are all known to
effect stability and sensitivity to stress agents such as antibi-
otics [39–42].
The enriched gene set was searched for genes that might be
involved in cell wall biosynthesis, and/or antibiotic targets.
Genes that were up-regulated and might be directly
involved in peptidoglycan biosynthesis encode an FtsI-like
PBP (sco3771), a putative muramoyl-pentapeptide carboxy-
peptidase (sco5467) and a putative deacetylase (sco2962).
Genes that were down-regulated encode a putative PG
deacetylase (sco6178), a putative AmpC b lactamase/
D-alanyl-D-alanine carboxypeptidase (sco5660), a putative
D-alanyl-D-alanine dipeptidase (sco1396) and a putative
murein DD-endopeptidase (sco0543). Enriched GO terms
did not include cell envelope biogenesis, and the expression
of the putative major PG biogenesis operon in S. coelicolor
(sco2077-sco2092) was unchanged in DT3017. Amongst the
down-regulated gene set, there were no obvious candidates
that might contribute to enhanced antibiotic susceptibility.
On the contrary, genes that are predicted to encode efflux
systems were up-regulated (sco5950, sco5516, sco3206,
sco1742 and sco0756) as well as one gene, sco4049, encoding
a putative penicillin amidase/acylase. Two up-regulated
genes have been linked with vancomycin resistance: sco6183
(cwgE), a GT1 putative heptosyl transferase that is part of
the vancomycin-induced putative cell wall glycan operon
(cwg) [43], and sco2472, a homologue of an uncharacterized
protein, SanA, that affects membrane permeability to van-
comycin [44].
The gene sco3736, encoding an ECF sigma factor and
the two upstream genes sco3737 and sco3738, encoding a
putative lipoprotein/sortase (homology to SrtE family –
cd05829; E=3e 51) and membrane protein, respectively, are
the most significantly up-regulated genes in the ppm1–
strain, DT3017 (13-, 37- and 32-fold, respectively) (Fig. 5).
The ECF sigma factor sco3450 is also 1.9 fold up-regulated
and there is a strong down-regulation (15-fold) of ECF
sigma factor gene, sco4938. It is worth emphasizing that the
expression of sco3356 encoding the known cell wall stress
ECF sigma factor, SigE, [45] did not change (Dataset S3).
The Ppm1-defective strain contains a higher
relative proportion of unsaturated fatty acids
Raman spectroscopy was used to investigate changes in the
fatty acid profile of the ppm1 mutant by means of quantita-
tive lipid phenotyping. The Raman spectroscopy approach
involves the inelastic scattering of light to produce high-
discriminatory, molecular-scale cell characterization (i.e.
fingerprinting). Raman fingerprinting provides detailed
information on the cellular components including proteins,
nucleic acids, lipids and carbohydrates [31, 46], and has
been used to characterize microbial species and subspecies,
and phenotypic changes [32, 47–49].
Raman spectroscopy was previously applied to lipid profiling
in several studies. Wu et al. correlated the relative intensities
of the 1650 cm 1 C=Cand 1440 cm 1 CH2 Raman bands
(I1650/I1440 ratio) to the degree of lipid unsaturation in
extracted lipids from algae cells [50]. Potcoava et al. used the
degree of unsaturation (I1655/I1440 and I1655/I1294), lipid chain
length (I2930/I2959) and total unsaturated fatty acid (TUFA) to
total fatty acid (TFA) (I3015/I2851) ratios to characterize lipid
droplets in treated and untreated breast and prostate cancer
cells, noting that the TUFA/TFA ratio correlates to the num-
ber of C=C to CH2 species in pure fatty acids [51]. The
TUFA/TFA ratio has also been used by Nieva et al. to stratify
Fig. 3. Transcription of vanH in response to vancomycin induction. qRT-PCR was performed to measure relative levels of vanH mRNA
following addition of 0.1 µgml 1 vancomycin to (a) DT3017 (blue; ppm1–) and (b) DT2008 (red; pmt–) strains alongside the parent strain
(black;J1929) and their respective complemented strains (grey; panel a; DT3017:pDT16 and panel b; DT2008:pDT10). In each instance
hrdB was used as the reference gene and J1929 time-point 0 as the reference sample.
Howlett et al., Microbiology
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the degree of malignancy in breast cancer cells, and is
regarded as a key Raman biomarker for lipid phenotyping
[52]. Whereas peak intensity ratios for the degree of lipid
unsaturation and chain length also relate to proteins, the
TUFA/TFA ratio comprises lipid molecule vibrations only
[31] and is therefore a reliable biomarker to interrogate the
fatty acids in intact cells. In this work, the TUFA/TFA ratio
was used to determine changes in the lipid content of the par-
ent S. coelicolor strain J1929, the ppm1 mutant derivative,
DT3017 and the complemented mutant, DT3017:pDT16.
Averaged Raman spectra and peak assignments obtained for
J1929, DT3017 DT3017:pDT16 (Figs 6 and S3, Table S3)
agree with previously published spectra for Streptomyces
cells [32] and other published works on bacteria [48]. The
TUFA/TFA peak intensity ratios determined from these
spectra showed that the parent strain, J1929, and the com-
plemented mutant DT3017:pDT16 have similar lipid
composition (Fig. 6c). For the DT3017 ppm1 strain, the
TUFA/TFA value was outside of the J1929 and DT3017:
pDT16 ranges, confirming that it has a larger relative unsat-
urated fatty acid component and hence different lipid com-
position. The converged percentage standard error of the
mean for the TUFA/TFA values as a function of the number
of randomly selected individual spectra in the spectral aver-
ages indicated that sufficient data were collected (N=40–55
spectra/strain) to establish reliable statistics for these meas-
urements (Fig. S3).
DISCUSSION
Previous work has shown that mutations in the genes
encoding Ppm1 and Pmt required for synthesis of polypre-
nol phosphate mannose (PPM; ppm1) and O-glycoproteins
(pmt and ppm1) in Streptomyces coelicolor lead to phage
resistance [9, 21, 22]. Here we show that pmt– and ppm1–
Table 1. Enriched GO terms
Count of genes associated with the listed
GOID in the dataset
Count of genes associated with the listed
GOID in the full gene list
P value
Up-regulated enriched GO terms
Organic acid biosynthetic process 31 276 0.000
Cytoplasm (cellular component) 42 984 0.004
Fatty acid synthase activity (molecular-function) 5 25 0.034
Nickel cation binding (molecular-function) 4 13 0.029
Carboxylic acid biosynthetic process 31 268 0.000
Nucleoside catabolic process 3 7 0.053
Nucleoside phosphate biosynthetic process 9 109 0.078
Cellular amino acid biosynthetic process 19 179 0.000
Monocarboxylic acid biosynthetic process 12 82 0.000
Nucleoside monophosphate biosynthetic process 6 43 0.053
Glutamine family amino acid biosynthetic process 10 35 0.000
Alpha-amino acid biosynthetic process 18 150 0.000
Fatty acid biosynthetic process 9 64 0.003
Branched-chain amino acid biosynthetic process 5 19 0.010
Ribonucleoside monophosphate biosynthetic process 6 39 0.034
Biotin biosynthetic process 3 7 0.053
Arginine biosynthetic process 7 15 0.000
Leucine biosynthetic process 3 7 0.053
‘De novo’ UMP biosynthetic process 3 7 0.053
Down-regulated enriched GO terms
Periplasmic space (cellular-component) 17 83 0.002
Transport 57 693 0.054
Single-organism catabolic process 19 151 0.069
Organic substance transport 31 261 0.008
Organic acid transport 13 69 0.020
Carbohydrate transport 13 80 0.062
Anion transport 16 97 0.018
Monocarboxylic acid catabolic process 14 63 0.003
Carboxylic acid transport 13 69 0.020
Fatty acid metabolic process 16 108 0.053
Fatty acid catabolic process 10 27 0.002
Amino acid transport 13 61 0.008
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mutations also lead to an increase in susceptibility to antibi-
otics, particularly those that target cell wall biogenesis. We
propose that in ppm1– strains, the extremely antibiotic-sus-
ceptible phenotype is due to global changes in lipid, mem-
brane and periplasmic protein functions. The pmt mutants
have a similar but less extreme phenotype to the ppm1
mutants, suggesting that loss of membrane and periplasmic
glycoproteins contributes to antibiotic hyper-susceptibility.
The ppm1 mutants show greater sensitivity to vancomycin
and b-lactams, and higher susceptibility to a greater range
of antibiotics that target membrane or periplasmic enzymes
than pmt– mutant strains (Fig. 2). ppm1 mutants fail to gen-
erate the lipid-linked mannose donor, polyprenol phosphate
mannose, PPM, whereas pmt– strains are able to generate
PPM but fail to use PPM in protein O-glycosylation
[9]. Streptomyces spp. have been shown to produce
Fig. 4. Expression of genes involved in fatty acid metabolism in the ppm1– strain DT3017, the parent strain, J1929 and the comple-
mented strain DT3017:pDT16. (a) Pathway for the synthesis of fatty acids in S. coelicolor. The thick line feeding into reaction 3 reflects
the preference by S. coelicolor FabH for branched-chain acyl-CoA precursors [83] (b) Deseq normalized expression levels for fatty acid
metabolism genes of S. coelicolor for strains J1929 (black), DT3017 (red) and DT3017 pDT16 (grey). Red numbering above refers to
steps in the pathway indicated in (a) above. Shown values are the average of three replicates. Above DT3017 one star equals
P<0.05 and two stars equal Benjamini–Hockberg-corrected P<0.05 significance levels against J1929.
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phosphotidylinositolmannosides (PIMs) whose synthesis
could also require PPM, depending on the degree of manno-
sylation [53, 54]. In mycobacteria myo-inositol is sequen-
tially mannosylated generating PIM1 to PIM6, with PPM
acting as the sugar donor for the later steps in the pathway
[55]. S. coelicolor contains close homologues of the
M. tuberculosis genes required for PIM biosynthesis:PimA
(Rv2610c, SCO1525; E=3e 122) and PimB (Rv2188c,
SCO2132; E=9e 127) that synthesize myo-inositol with one
(PIM1) or two (PIM2) mannose residues attached, respec-
tively. Both PimA and PimB act on the inner face of the
cytoplasmic membrane and use GDP-mannose as the sugar
donor. PimE in M. tuberculosis uses PPM to transfer man-
nose to the growing mannose chain, i.e. PIM4 to PIM5.
SCO2335 is a distant (E=4e 15) homologue of M. tuberculo-
sis PimE (Rv1159) and could be involved in the polymeriza-
tion of the mannoside chain using PPM as the sugar donor.
Another candidate protein from S. coelicolor that could uti-
lize PPM is SCO4023, which is annotated as a dolichyl-
phosphate-mannose protein mannosyltransferase (PMT_2,
Pfam13231). The gene sco4023 is located adjacent to
sco4022, which is a homologue of ppm1. In preliminary
work we have knocked out both of these genes, and muta-
tion in neither gene confers resistance to fC31 (Dr Anpu
Varghese, unpublished work). According to the Carbohy-
drate Active Enzymes (CAZY) database (www.cazy.org), the
S. coelicolor genome encodes 29 and 17 GT2 and GT4 family
glycosyl transferases, respectively; members of both families
can use polyprenol-containing glycoconjugates as sub-
strates. Loss of PPM from the S. coelicolor membrane is
therefore expected to affect synthesis of periplasmic O-gly-
coproteins, periplasmic mannosylation of PIMs and, possi-
bly, a variety of as yet uncharacterized cell envelope
macromolecules. While disruption of the O-glycosylation
pathway by mutation of pmt leads to mild antibiotic
hypersusceptibility, the extreme antibiotic hyper-suscepti-
bility when PPM is depleted indicates that multiple path-
ways depend on PPM as a sugar donor.
RNAseq was used to provide insight into the global changes
in the ppm1– mutant strain compared to its parent. The
ppm1– strain has undergone a major shift from a largely cata-
bolic metabolism to an anabolic one. Genes coding for mem-
brane and periplasmic proteins, particularly transport
proteins, were down-regulated in the ppm1 mutant, DT3017,
whereas genes for biosynthetic cytoplasmic functions were
up-regulated. This response might be expected after transfer
of a bacterial culture to a minimal medium where biosyn-
thetic functions would be up-regulated. However, the growth
of all the strains for RNAseq was performed in rich medium
(Difco nutrient broth). The logical interpretation of the
switch from the parental catabolic metabolism to the ppm1
mutant anabolic metabolism is that some systems for sensing
nutrients and their uptake are defective. At this stage we can-
not, however, propose a direct mechanism through which
loss of PPM might lead to the observed metabolic switch,
other than multiple effects caused by a lack of mannose-con-
taining glycoconjugates in the cell envelope and/or an accu-
mulation of polyprenol phosphate.
Differential gene expression showed a switch in fatty acid
metabolism in the ppm1– strain, with genes coding for
b-oxidation enzymes down-regulated and those for synthe-
sis up-regulated (Table 1; Fig. 4) [25, 56]. The up-regulation
of the ACC complex might have increased the proportion of
straight-chain fatty acids as ACC, but not the PCC complex,
can use acetyl-CoA as a primer for FA biosynthesis [56]. To
study lipids in the Streptomyces strains, we used Raman
spectroscopy of whole cells. The ppm1– mutant was shown
to have a small but significant increase in the ratio of TUFA
acids to total fatty acids (TFA) compared to the TUFA/TFA
Fig. 5. RNAseq mapped read depth across SCO3736–SCO3738, the genes most significantly changed in DT3017. Deseq analysis of dif-
ferential gene expression between J1929 and DT3017 revealed that the top three most significant changes occurred in one operon,
SCO3736–SCO3738, encoding a putative extracytoplasmic sigma factor, lipoprotein and integral membrane protein, respectively.
Shown are the mapped read depths across this region alongside downstream SCO3735, a putative secreted protein, as visualized by
the Integrated Genomics Viewer. Replicate one is shown as representative of all replicates.
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ratios in the parent strain or the complemented mutant. The
only enzyme in Streptomyces known to introduce the C=C
double bond in FA biosynthesis is FabA (SCO4636 and
SCO4637), a hydroxyacyl-ACP dehydratase [57], and the
corresponding genes are up-regulated in the ppm1 mutant.
Up-regulation of fabA in E. coli is known to lead to a higher
proportion of unsaturated FAs [25, 58, 59]. However, it is
not clear whether up-regulation of the fabA genes in the
S. coelicolor ppm1- mutant led directly to the observed
higher TUFA/TFA ratio or whether the up-regulation is
simply in line with the overall up-regulation of the FA bio-
synthesis pathway. The net result, however, is a change in
lipid composition in the ppm1– strain DT3017 compared to
its parent.
Changes in lipid composition can have profound effects on
the activities of membrane proteins, perhaps providing a
mechanism for the proposed defects in periplasmic nutrient
sensing and transport protein function. Membrane composi-
tion is important in maintaining the topology of membrane
proteins. Although the ‘positive inside rule’ is believed to be
the major determinant of membrane protein topology, head
group charge, fatty acid chain length and fatty acid unsatura-
tion have also been shown to be important [60]. Pertinent to
our work is that changes in membrane composition are also
correlated with changes in sensitivity to antibiotics and/or
detergents. For example, a B. subtilis strain lacking three
extracytoplasmic functions, ECF, sigma factors (sM, sW and
sX) is significantly more sensitive to cell wall-acting antibiot-
ics than either the double mutants or the parents [61].
Expression of sW was shown to lead to a decrease in mem-
brane fluidity with concomitant increase in resistance to
detergents [42]. The S. coelicolor ppm1 mutants are highly
susceptible to daptomycin, an antibiotic that targets the cyto-
plasmic membrane, possibly causing depolarization, and in
Enterococcus faecalis inhibits cell division by concentrating at
the septum [62]. Changes in membrane fluidity have been
associated with daptomycin resistance in S. aureus; in vitro-
derived daptomycin-resistant strains have increased mem-
brane fluidity, although highly fluid membranes also display
increased resistance to cationic peptides including daptomy-
cin, supporting the view that membrane fluidity is only one
component of the cell envelope that mediates susceptibility to
this antibiotic [39, 62, 63]. A decrease in the supply of unde-
caprenol phosphate (uppS mutant) in B. subtilis can lead to
increased vancomycin resistance, and this was shown to be
due to elevated sM expression. Mutation in a teichoic acid
biosynthesis gene (TagF) can also increase sensitivity to van-
comycin and lysozyme in Streptomyces [64].
Fig. 6. Raman spectroscopy analysis of S. coelicolor strains. Averaged Raman spectra obtained in the (a) high-wave number region
and (b) the fingerprint region (600–1800 cm 1) for the S. coelicolor parent strain J1929 (red; N=42), the ppm1- mutant strain DT3017
(blue; N=55) and the complemented mutant, DT3017:pDT16 (red; N=40). N refers to the total number of individual spectra in each spec-
tral average. Key peak assignments are shown (Table S3) with the spectra vertically shifted to aid visualization. Panel c; TUFA/TFA
(I3008/I2850) peak intensity ratios derived from the averaged spectra in panels a and b.
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Gene regulation by ECF sigma factors is important in
B. subtilis in sensing and reacting to cell wall stresses [65].
The RNAseq data on the S. coelicolor ppm1- mutant showed
significant changes in expression of regulators, but not
where expected. For example, genes for sigma factors such
as SigE (sco3356, linked to cell wall stress; [45]), SCO0600
(sigB; osmotic stress; [66]), SCO2954 (linked to increased
expression of extracellular proteases; [67]), SCO4005 (up-
regulated by ppGpp; [68]) and SCO4938 were down-regu-
lated in the ppm1– strain DT3017. Three of four of the most
significantly up-regulated genes in DT3017 were the conse-
cutive genes sco3736–sco3738, probably co-transcribed and
encoding a putative ECF sigma factor, a lipoprotein with
putative sortase E function, and integral membrane protein,
respectively (Fig. 5). Sortases are transpeptidases that attach
proteins to the cell wall [69]. The major ‘housekeeping’ sor-
tase normally recognizes a conserved pentapeptide sorting
sequence in a variety of substrates that in S. coelicolor is pre-
dicted to be LAXTG [70]. Sortase E homologues are thought
to have a more specific range of substrates, and two of these,
SCO3849 and SCO3850, have been shown to be required
for normal development in S. coelicolor [71]. SCO3737
belongs to a more divergent group of putative sortases and
it has been proposed that genes for this group are co-tran-
scribed with their substrates. In the case of sco3737, this
would be sco3738 encoding a putative membrane protein
[69, 71]. A gene encoding a second putative ECF sigma fac-
tor, sco3450 (SigR2 transcribed by SigR, which mediates the
major thiol-oxidative stress response) [72, 73], is also up-
regulated. Both up-regulated sigma factors are expressed
early in the life cycle of Streptomyces; sco3736 and sco3450
were identified in a study examining regulatory networks
during germination [73].
The changes in the complement of sigma factors in DT3017
might be directly responsible for the global phenotypic
response to growth without the ability to synthesize PPM.
Changes in sigma factors might also explain why ppm1 and
pmt mutants are more sensitive to rifampicin, an antibiotic
inhibiting transcription initiation by binding within the
DNA/RNA channel of the b-subunit of RNA polymerase
[74]. Although rifampicin is considered a general inhibitor
of RNA polymerase, there are examples of altered promoter
responses to rifampicin for differing holo-enzymes. These
include: the tdc operon is insensitive to rifampicin [75] and
there is increased sensitivity to rifampicin in vivo and in
vitro for s70-RNApol over s32-RNApol in E. coli [76]. In
B. subtilis SigB dependent transcription is less sensitive to
rifampicin [77], and transcription of a sigR-dependent pro-
moter is more resistant to rifampicin than transcription of a
hrdB-dependent promoter (rrn) [78].
The pmt mutants are, like the ppm1 mutants, considerably
more sensitive to vancomycin and b-lactams (including
ampicillin and imipenem) than the parent strain (Fig. 2).
Our hypothesis, which is consistent with the mechanism of
protein mannosyl transferases in yeasts and in another acti-
nobacterium, M. smegmatis, is that secreted and membrane
proteins are targets for O-glycosylation [2, 9, 13] and that
the modification affects protein function. It has been estab-
lished by others that protein glycosylation can have an
impact on protein function [79, 80], and it has recently been
shown to have a role in regulating the function of a peptido-
glycan hydrolase [81]. The relative activities of transpepti-
dase and carboxypeptidase cell wall biosynthesis enzymes
are known to play a role in providing intrinsic vancomycin
resistance in S. coelicolor, suggesting that subtle changes to
protein activities could have a large effect on antibiotic sen-
sitivities [82]. Our observations are reminiscent of the phe-
notypes of PMT mutants of fungi, where the most common
phenotype is increased susceptibility to cell wall-acting
inhibitors [2]. The consistency across kingdoms in the phe-
notypes of pmt mutants implies that O-glycosylation has
similar roles in protein function in fungi and bacteria.
Both pmt and ppm1 mutants are highly susceptible to
vancomycin, despite the presence in S. coelicolor of
the vanRSJHAX gene cluster conferring resistance [33, 34].
This cluster is induced by vancomycin, which binds the
VanS sensor protein and, through phosphorylation of
VanR, switches on the van promoters. We showed that the
van genes are induced normally by vancomycin in the ppm1
and pmt mutants, and yet the strains are still very sensitive
to the antibiotic. There are two possible explanations for the
persistent sensitivity to vancomycin: either the substrates
for the resistance enzymes to generate the D-ala-D-lac penta-
peptides are in limited supply or resistance could be masked
epistatically by membrane-associated steps such as flipping
of lipid II, or the lipid II polymerization steps transglycosy-
lation and transpeptidation. In the ppm1mutant, changes in
membrane physiology are predicted by RNAseq analysis
and observed through Raman spectroscopy, arguing that
perturbation of membrane-associated steps in peptidogly-
can biosynthesis might be responsible for preventing the
normal ability of van gene products to deliver resistance to
vancomycin.
In summary we have provided insights into the complex
phenotypes of mutants in S. coelicolor that lack the ability to
synthesize PPM and O-glycoproteins. We have presented
evidence for a remodelling of the plasma membrane in
terms of the protein and fatty acid components, possibly
mediated by changes in ECF sigma factors in the ppm1–
mutant. The result of these adaptations is a loss of intrinsic
resistance to antibiotics that target cell wall biogenesis, par-
ticularly those that act outside the plasma membrane, and to
rifampicin. As the pmt– mutant strains have also lost some
intrinsic resistance to a similar subset of antibiotics (particu-
larly vancomycin, imipenem and rifampicin) as the ppm1–
strain, we conclude that loss of protein O-glycosylation con-
tributes in part to the phenotype of the ppm1– strains.
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